Navigation Links
Haemonetics Reports 2nd Quarter Fiscal 2014 Revenue Up 8%; Adjusted Operating Margin Up 260 Basis Points; and $0.66 Adjusted EPS Up 24%
Date:10/28/2013

ally, the Company repaid $20 million of outstanding debt in the second quarter and anticipates $17 million will be utilized for scheduled repayments in the second half of fiscal 2014.

In total $82 million, comprised of the $72 million of cash transformation expenditures plus up to $10 million of non-cash asset write-offs associated with planned plant closures, will be excluded from adjusted earnings in fiscal 2014.  More information on fiscal year 2014 guidance, including income statement scenarios underlying the lower and upper ends of the adjusted earnings per share guidance range, can be found in the Investor Relations section of our web site at http://www.haemonetics.com.1

ADJUSTMENTS TO SECOND QUARTER REPORTED EARNINGSIn total $19 million of charges, comprised of the $16 million of VCC transformation and $3 million of integration activities, were excluded from adjusted earnings in the second quarter of fiscal 2014.  Approximately 31% of such charges established reserves that did not require the current disbursement of cash.  The Company excluded $23.7 million of pre-tax restructuring, transformation and transaction costs from adjusted earnings in the second quarter of fiscal 2013.

The Company excludes acquisition related amortization expenses from its adjusted earnings and EPS, beginning in fiscal 2014, and prior period amounts have been conformed to permit comparison.  Excluded from second quarter adjusted earnings were $6.9 million in fiscal 2014 and $6.1 million in fiscal 2013, or $0.09 and $0.08 per share, respectively. 

On a year-to-date basis, $13.6 million in fiscal 2014 and $8.8 million in fiscal 2013, or $0.18 and $0.12 per share, respectively, of such costs were excluded.

BALANCE SHEET AND CASH FLOWCash on hand was $159 million, a decrease of $7 million during the second quarter.  The Company reported first half fiscal 2014 free cas
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. FDA Approvals, Dividends, New Technologies, and Solid Margins Increase Shareholder Value - Research Report on Abbott, Baxter, CareFusion, Haemonetics, and CR Bard
2. Haemonetics Reports 1st Quarter Fiscal 2014 Revenue Up 24%; Adjusted EPS of $0.46 Up 46%; Adjusted Operating Margin Improvement of 270 Basis Points; and Significant Progress on Planned Manufacturing Transformation
3. The Zacks Analyst Blog Highlights: Walgreens, Express Scripts Holding, Haemonetics, ResMed and Eli Lilly
4. Haemonetics Announces Next Steps in Manufacturing Transformation
5. Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference
6. Haemonetics Completes Hemerus Medical, LLC Acquisition
7. Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidanc
8. Haemonetics Sets Date for Investor/Analyst Meeting
9. Haemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70
10. Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
11. Haemonetics Completes Acquisition of Palls Transfusion Medicine Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 2014  Varian Medical Systems (NYSE: VAR ... the fourth quarter of fiscal year 2014 following the ... The news release will be followed by a teleconference ... The news release and a link to the conference ... at: www.varian.com/investor .  To access the teleconference call ...
(Date:10/1/2014)... 2014   Royal Philips (NYSE: ... eCareCoordinator and eCareCompanion telehealth applications have received 510(k) ... (FDA). A part of Philips Hospital to Home,s ... eCareCompanion are focused on patient care within the ... be available through the cloud-based digital health platform, ...
(Date:10/1/2014)... 1, 2014 Sophia Genetics, ... domaine de l,analyse des données issues du SNG ... de diagnostic in vitro (IVD) du gène CFTR ... la mucoviscidose dans un seul essai SGN. La ... les types de variantes par l,intermédiaire d,un seul ...
Breaking Medicine Technology:Varian Medical Systems Schedules Fourth Quarter FY2014 News Release and Conference Call 2Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 2Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 3Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 4Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 2Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 3
... Medical School ,Contributing Editor , ,With over ... breast cancer undoubtedly qualifies as one of Americas ... develop early detection methods and more effective therapy ... true at the molecular level, where discoveries on ...
... located on the short arm of chromosome 6 (6p21.3), is ... HLA region is the human equivalent of the Major Histocompatibility ... that serve as the backbone of antigen presentation. The ... CD8+ T-cells, are expressed by genes located in the HLA-A, ...
Cached Medicine Technology:Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 2Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 3The Past, Present and Future of HLA Typing 2The Past, Present and Future of HLA Typing 3
(Date:10/1/2014)... Phoseon Technology, the pioneer in developing ... the business worldwide. This rapid growth includes increased hiring ... manufacturing efforts. The company has experienced average annual growth ... expects this growth to continue in the future as ... adoption. , “We are very pleased that ...
(Date:10/1/2014)... 2014 Farmington Company today announced ... mission and visual identity helping brokers, consultants and ... them to create greater benefit communication synergies. They ... on empowering customers to better leverage Farmington Company’s ... jewel of the rebrand is the refreshed tagline: ...
(Date:10/1/2014)... A new genetic finding from Duke Medicine suggests that ... depression might also be hard-wired to gain weight when ... disease. , An estimated 13 percent of people, all ... and knowing this could help them reduce heart disease ... and stress management. , "Genetic susceptibility, psychosocial stress and ...
(Date:10/1/2014)... Kennebunkport, Maine (PRWEB) October 01, 2014 ... autoimmune disorders in the U.S., according to figures from ... Autoimmune Related Diseases Association (AARDA), and many of them ... higher chance of having undiagnosed celiac disease. Gluten ... helping raise awareness of undiagnosed celiac disease by publishing ...
(Date:10/1/2014)... 2014 Diet Doc understands that many of ... weight and their dieting attempts could be easily sabotaged by ... hormone diet treatments into their programs as a way ... fast and effective weight loss results, it also allows patients ... to maintain their weight for the future. , Earlier versions ...
Breaking Medicine News(10 mins):Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4
... cancer patients who exhibit limited lymph node involvement may ... neoadjuvant chemotherapy before a mastectomy, according to researchers from ... , The findings were reported today at the ... Radiology and Oncology. , "Radiation after surgery has been ...
... can affect practice behavior in inquiries about patient mood ... study led by University of Rochester Medical Center researchers. ... or attitudes, are loathe to broach sensitive topics such ... professor of psychiatry at the Medical Center and lead ...
... 24 As Senators Barack,Obama and John McCain arrive ... be greeted by AIDS activists from across the,country demanding ... his first 100 days in office., On Friday, ... the debate -,AIDS activists will hold a demonstration and ...
... Cooper University,Hospital in Camden, N.J., has agreed ... interest, to settle allegations that it defrauded ... settlement resolves allegations that the hospital improperly,increased ... reimbursement,from the federal health care program. In ...
... training in 60s, 70s wards off loss that weakens ... -- Strength training can help people build muscle mass to ... age until they reach 80, a new study says. , ... , The Ball State University study, sponsored by a ...
... The U.S. Pharmacopeial (USP) Convention is pleased to ... Material (CRM), Dextromethorphan Hydrobromide. USP recently became the ... Standardization accreditation as producer of chemical CRMs. ... new class of reference standard that ensures improved ...
Cached Medicine News:Health News:Cancer patients who receive neoadjuvant therapy followed by mastectomy may not need radiation 2Health News:Personality can hamper a physician's assessment of depression 2Health News:AIDS Activists from Across the Country Converge on Oxford, Mississippi, to Call on McCain and Obama to Commit to National AIDS Strategy 2Health News:New Jersey Hospital to Pay $3.85 Million to Resolve Allegations of Inflating Charges to Obtain Higher Medicare Reimbursement 2Health News:Boomers Should Add Muscle Before It's Too Late 2
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
... Fast-Cath, Maximum, Maximum Xtra, and ... line of standard and specialty hemostasis ... recognized as the premier hemostasis introducers ... electrophysiology procedures including angiography, angioplasty, stenting, ...
... to close arteriotomies with ease and ... a simple trigger actvated mechanism, requires ... sheath gently locks onto the target ... site before, during, and after the ...
The Prostar XL 10 is a suture mediated closure system. It can be used with 10F sheath. It has two 3-0 braided polyester sutures and also has the safety of guidewire....
Medicine Products: